Thermo Fisher Scientific Signs Agreement to Acquire Alfa Aesar
“The acquisition of Alfa Aesar enhances our existing portfolio of chemicals, solvents and reagents to support virtually every laboratory application – from research, to drug discovery and development, to production,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “In addition, customers will benefit from greater access to these products through our extensive global commercial reach.”
The transaction, which is expected to be completed by the end of 2015, is subject to customary closing conditions, including regulatory approvals. Alfa Aesar will be integrated into Thermo Fisher’s Laboratory Products and Services Segment.
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.